NOP56 Gene Spinocerebellar Ataxia Type 36 Autosomal Dominant NGS Genetic DNA Test
Introduction
The NOP56 Gene Spinocerebellar Ataxia Type 36 Autosomal Dominant NGS Genetic DNA Test is a specialized genetic examination designed to detect mutations in the NOP56 gene that are associated with Spinocerebellar Ataxia Type 36 (SCA36). This condition is a hereditary neurological disorder characterized by progressive loss of coordination and balance. Understanding one’s genetic predisposition is crucial for early diagnosis and management of this debilitating condition.
What the Test Measures
This test employs Next Generation Sequencing (NGS) technology to accurately identify mutations in the NOP56 gene. By analyzing the genetic material obtained from a blood sample or extracted DNA, the test can determine if an individual carries genetic variants that could lead to SCA36.
Who Should Consider This Test
Individuals with a family history of Spinocerebellar Ataxia or those experiencing symptoms such as:
- Loss of balance and coordination
- Difficulty with fine motor skills
- Speech difficulties
- Progressive muscle weakness
should consider undergoing this genetic test. Risk factors include a family history of neurological disorders and the presence of symptoms suggesting possible ataxia.
Benefits of Taking the Test
- Early diagnosis of potential genetic conditions.
- Informed decision-making regarding treatment and management.
- Genetic counseling for affected families.
- Understanding inheritance patterns and risks for future generations.
Understanding Your Results
Results from the NOP56 Gene test will indicate whether mutations were detected. A positive result suggests a higher risk for developing SCA36, while a negative result may provide relief but does not entirely rule out the possibility of ataxia. It is essential to discuss results with a qualified healthcare provider for comprehensive interpretation and guidance.
Test Pricing and Details
| Test Name | Discount Price | Regular Price |
|---|---|---|
| NOP56 Gene Spinocerebellar Ataxia Type 36 NGS Genetic DNA Test | KSh 40,000 | KSh 56,000 |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood or extracted DNA, and we also accept one drop of blood on an FTA card. Prior to testing, patients are advised to undergo a genetic counseling session to create a pedigree chart of affected family members.
Book Your Test
We have branches across all major cities in Kenya, making it convenient for you to access our services. To book the NOP56 Gene Spinocerebellar Ataxia Type 36 Autosomal Dominant NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Take the first step towards understanding your genetic health today!
